LEADER 01890nam  2200433   450 
001 9910712952703321
005 20200306110050.0
035   $a(CKB)5470000002498666
035   $a(OCoLC)1143391364
035   $a(EXLCZ)995470000002498666
100   $a20200306d2018      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies $etestimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives /$f/ statement of Debra A. Draper
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2018.
215   $a1 online resource (9 pages)
225 1 $aTestimony ;$vGAO-18-646T
300   $a"For release on delivery, expected at 10:00 a.m. ET, Wednesday, July 11, 2018."
320   $aIncludes bibliographical references.
517   $aDrug discount program
606   $aPrescription pricing$xLaw and legislation$zUnited States
606   $aDrug accessibility$xLaw and legislation$zUnited States
606   $aDrugs$xPrices$xLaw and legislation$zUnited States
606   $aPoor$xPharmaceutical assistance$zUnited States
615  0$aPrescription pricing$xLaw and legislation
615  0$aDrug accessibility$xLaw and legislation
615  0$aDrugs$xPrices$xLaw and legislation
615  0$aPoor$xPharmaceutical assistance
702   $aDraper$b Debra
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Health,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910712952703321
996   $aDrug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies$93462210
997   $aUNINA